**
RayzeBio seeks a Radiopharmaceutical Medical Science Liaison (RPT-MSL) to engage with Thought Leaders and healthcare professionals, enhancing the company's scientific leadership in oncology. The role, which is remote, focuses on building scientific partnerships, supporting clinical development, and delivering strategic insights to improve patient care.
**
Job Summary
The role will engage in authentic, peer-to-peer scientific dialogue with leading RPT Thought Leaders and HCPs to strengthen RayzeBio’s scientific leadership, accelerate patient impact and shape the future of care.
Support clinical development by identifying and recommending sites for trials, engaging with investigators and site staff to educate on the trial and asset and identify barriers to enrollment.
Benefit offerings include health coverage, wellbeing support, financial well-being and protection, and work-life benefits such as paid time off.
Matching Summary
Match Score: 75
**
RayzeBio seeks a Radiopharmaceutical Medical Science Liaison (RPT-MSL) to engage with Thought Leaders and healthcare professionals, enhancing the company's scientific leadership in oncology. The role, which is remote, focuses on building scientific partnerships, supporting clinical development, and delivering strategic insights to improve patient care.
**
Salary
Base: $149,860 - $181,595; Bonus/Equity: Additional incentive cash and stock opportunities may be available; Benefits: Health Coverage, Wellbeing Support, Financial Well-being and Protection, Paid Time Off
Skills & Requirements
Must-have
Radiopharmaceutical therapies
Scientific dialogue with Thought Leaders
Support clinical development
Gather actionable insights
Deliver business-critical recommendations
Engage with national and global Thought Leaders
Nice-to-have
Agile and adaptable mindset
Passion for science
Collaborative team player
Key Requirements
MD, PhD, PharmD (or equivalent) or related RPT specialty
7-10+ years of experience in oncology and/or RPT
Minimum of 3 years of field experience with an RPT or solid tumor product